Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing

• Autori principali: Thiviyadarshini Rajasegaran (Autore), Chee Wun How (Autore), Anoosha Saud (Autore), Azhar Ali (Autore), Jonathan Chee Woei Lim (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2023-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Lung cancer is the most common cause of cancer-related deaths. Lung cancers can be classified as small-cell (SCLC) or non-small cell (NSCLC). About 84% of all lung cancers are NSCLC and about 16% are SCLC. For the past few years, there have been a lot of new advances in the management of NSCLC in te...